Inflammation and Stroke Risk: A New Target for Prevention.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34162215.
- Also identified by DOI 10.1161/STROKEAHA.121.034388.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
New therapeutic approaches are required for secondary prevention of residual vascular risk after stroke. Diverse sources of evidence support a causal role for inflammation in the pathogenesis of stroke. Randomized controlled trials of anti-inflammatory agents have reported benefit for secondary prevention in patients with coronary disease. We review the data from observational studies supporting a role for inflammation in pathogenesis of stroke, overview randomized controlled trials of anti-inflammatory therapy in cardiac disease and discuss the potential implications for stroke prevention therapy.
Medical subject headings
- Anti-Inflammatory Agents
- Drug Delivery Systems
- Secondary Prevention
- Stroke